-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOCARE ANNOUNCES ORELABRUTINIB IN COMBINATION WITH MESUTOCLAX GRANTED BREAKTHROUGH THERAPY DESIGNATION IN CHINA

Reuters·08/04/2026 02:48:26

Please log in to view news